BusinessWeek - Humana Inc.: Standard & Poor's equity analyst Phillip Seligman reiterated a buy rating on shares of health insurer Humana Inc. on Oct. 1.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.